ATE295172T1 - Propylaxe und behandlung der arzneimittel induzierten nierenstörungen - Google Patents

Propylaxe und behandlung der arzneimittel induzierten nierenstörungen

Info

Publication number
ATE295172T1
ATE295172T1 AT99906500T AT99906500T ATE295172T1 AT E295172 T1 ATE295172 T1 AT E295172T1 AT 99906500 T AT99906500 T AT 99906500T AT 99906500 T AT99906500 T AT 99906500T AT E295172 T1 ATE295172 T1 AT E295172T1
Authority
AT
Austria
Prior art keywords
drug
propylaxis
treatment
kidney disorders
induced kidney
Prior art date
Application number
AT99906500T
Other languages
English (en)
Inventor
Mikio Okamura
Yoshiharu Kanayama
Junichi Yoshikawa
Haruo Shintaku
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of ATE295172T1 publication Critical patent/ATE295172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99906500T 1998-02-27 1999-02-26 Propylaxe und behandlung der arzneimittel induzierten nierenstörungen ATE295172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4815898 1998-02-27
PCT/JP1999/000916 WO1999043324A1 (en) 1998-02-27 1999-02-26 Preventives or remedies for drug-induced renal disturbance

Publications (1)

Publication Number Publication Date
ATE295172T1 true ATE295172T1 (de) 2005-05-15

Family

ID=12795582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906500T ATE295172T1 (de) 1998-02-27 1999-02-26 Propylaxe und behandlung der arzneimittel induzierten nierenstörungen

Country Status (7)

Country Link
US (1) US6288067B1 (de)
EP (1) EP1004308B1 (de)
JP (1) JP4486167B2 (de)
AT (1) ATE295172T1 (de)
DE (1) DE69925225T2 (de)
ES (1) ES2242381T3 (de)
WO (1) WO1999043324A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008516A1 (en) * 1996-08-30 1998-03-05 Suntory Limited Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
WO2006055511A2 (en) * 2004-11-17 2006-05-26 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
HRP20220188T3 (hr) 2007-04-11 2022-04-29 Biomarin Pharmaceutical Inc. Načini primjene tetrahidrobiopterina, povezani pripravci i postupci mjerenja
WO2012103520A1 (en) * 2011-01-28 2012-08-02 Board Of Regents Of The University Of Nebraska Methods and compositions for modulating cyclophilin d
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
US11040007B2 (en) 2017-01-24 2021-06-22 Woosung Pharmaceutical Co., Ltd. Injection composition containing acetaminophen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
ZA836957B (en) * 1982-09-20 1985-04-24 Wellcome Found Neurologically active chemical compounds
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
JPH02157755A (ja) 1988-12-09 1990-06-18 Daito Denshi Color Kk 自動給液システム
AU9084991A (en) * 1990-11-01 1992-05-26 Board Of Regents, The University Of Texas System Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
WO1998008516A1 (en) * 1996-08-30 1998-03-05 Suntory Limited Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)

Also Published As

Publication number Publication date
ES2242381T3 (es) 2005-11-01
EP1004308A4 (de) 2001-03-14
EP1004308A1 (de) 2000-05-31
DE69925225D1 (de) 2005-06-16
EP1004308B1 (de) 2005-05-11
JP4486167B2 (ja) 2010-06-23
DE69925225T2 (de) 2006-02-23
US6288067B1 (en) 2001-09-11
WO1999043324A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
DE69526918D1 (de) Arzneimittel gegen spinocerebellare degeneration
WO2001072728A3 (en) Novel piperazine derivatives
WO2002032900A3 (en) Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
EP0795548A4 (de) Chinazozin derivate und deren verwendung
DE69725721D1 (de) Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
CA2313122A1 (en) Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
WO2003024955A3 (en) Small molecule inhibitors of caspases
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
DK1664041T3 (da) Phenylcarboxamidforbindelser, der er egnede til behandling af smerter
YU37203A (sh) Derivati supstituisanih 2-fenilaminoimidazolin-fenil- ketona kao ip antagonisti
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
CA2336412A1 (en) Medicament for treatment of diabetes
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
WO2002032901A3 (en) Bridged piperazine derivatives
ATE295172T1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
ATE340575T1 (de) Vorbeugung und behandlung von krankheiten in zusammenhang zu vaskularen funktionellen stoerungen un verbindung mit insulinresistenz
WO2002026732A1 (en) Benzodiazepine derivative
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
EP1393747A4 (de) Mittel zur prävention/behandlung von alzheimer-krankheit
WO2005053702A3 (en) Anti-inflammatory agents
MX9206930A (es) Nuevos compuestos
SE9704770D0 (sv) New use
EP0201349A3 (de) Tetrazolderivate
EP0641564A4 (de) Optisch aktive kondensierte pyrazolverbindungen zur verwendung in der behandlung von thrombozytopenie und erythropenie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties